LDN PHARMA LIMITED
Overview
Company Name | LDN PHARMA LIMITED |
---|---|
Company Status | Active |
Legal Form | Private limited company |
Company Number | 09400979 |
Jurisdiction | England/Wales |
Date of Creation |
Summary
Has Super Secure PSCs | No |
---|---|
Has Charges | No |
Has Insolvency History | No |
Registered Office is in Dispute | No |
What is the purpose of LDN PHARMA LIMITED?
- Manufacture of basic pharmaceutical products (21100) / Manufacturing
- Other human health activities (86900) / Human health and social work activities
Where is LDN PHARMA LIMITED located?
Registered Office Address | 45 Gresham Street EC2V 7BG London England |
---|---|
Undeliverable Registered Office Address | No |
What are the latest accounts for LDN PHARMA LIMITED?
Overdue | No |
---|---|
Next Accounts | |
Next Accounts Period End On | Jun 30, 2025 |
Next Accounts Due On | Mar 31, 2026 |
Last Accounts | |
Last Accounts Made Up To | Jun 30, 2024 |
What is the status of the latest confirmation statement for LDN PHARMA LIMITED?
Last Confirmation Statement Made Up To | Jul 31, 2026 |
---|---|
Next Confirmation Statement Due | Aug 14, 2026 |
Last Confirmation Statement | |
Next Confirmation Statement Made Up To | Jul 31, 2025 |
Overdue | No |
What are the latest filings for LDN PHARMA LIMITED?
Date | Description | Document | Type | |
---|---|---|---|---|
Confirmation statement made on Jul 31, 2025 with updates | 9 pages | CS01 | ||
Statement of capital following an allotment of shares on Mar 31, 2025
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Mar 21, 2025
| 3 pages | SH01 | ||
Unaudited abridged accounts made up to Jun 30, 2024 | 11 pages | AA | ||
Statement of capital following an allotment of shares on Oct 17, 2024
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Sep 19, 2024
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Aug 23, 2024
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Aug 12, 2024
| 3 pages | SH01 | ||
Confirmation statement made on Jul 31, 2024 with updates | 8 pages | CS01 | ||
Statement of capital following an allotment of shares on Jan 10, 2024
| 3 pages | SH01 | ||
Unaudited abridged accounts made up to Jun 30, 2023 | 11 pages | AA | ||
Statement of capital following an allotment of shares on Aug 29, 2023
| 3 pages | SH01 | ||
Confirmation statement made on Jul 31, 2023 with updates | 8 pages | CS01 | ||
Statement of capital following an allotment of shares on Apr 19, 2023
| 3 pages | SH01 | ||
Unaudited abridged accounts made up to Jun 30, 2022 | 12 pages | AA | ||
Registered office address changed from 25 Moorgate London EC2R 6AY England to 45 Gresham Street London EC2V 7BG on Aug 18, 2022 | 1 pages | AD01 | ||
Confirmation statement made on Jul 31, 2022 with updates | 8 pages | CS01 | ||
Statement of capital following an allotment of shares on Jul 27, 2022
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Feb 23, 2022
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Feb 02, 2022
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Jan 07, 2022
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Sep 16, 2021
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Aug 24, 2021
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Aug 23, 2021
| 3 pages | SH01 | ||
Statement of capital following an allotment of shares on Jun 30, 2021
| 3 pages | SH01 | ||
Who are the officers of LDN PHARMA LIMITED?
Name | Appointed On | Resigned On | Role | Address | Company Identification | Country of Residence | Nationality | Date of Birth | Occupation | Number | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BURTON, Graham Henry | Director | Indian River Drive 32963 Vero Beach 4005 Florida Usa | United States | American | Consultant | 199416100001 | ||||||||
DALGLEISH, Angus George | Director | Burdon Lane SM2 7PP Cheam 7 Surrey United Kingdom | United Kingdom | British | Professor Of Oncology, London | 52081310001 | ||||||||
MITCHELL, Michael Dennis, Henry | Director | 3040 Huldenberg Schonenberg 29 Belgium | Belgium | British | Company Director | 188691680001 | ||||||||
SWEENEY, Paul Joseph | Director | Letterkenny Co. Donegal Dromore Ireland | Ireland | Irish | Consultant/Advisor | 239477250001 | ||||||||
THOMPSON, Ian | Director | Carricklee Road BT82 9SE Strabane 1 Northern Ireland | Northern Ireland | Irish | Consultant/Advisor | 164312130001 | ||||||||
GORDON, Michael Thomas | Director | Calleva Park Aldermaston RG7 8NN Reading 5 Jupiter House Berkshire United Kingdom | England | British | Director | 135479350001 | ||||||||
@UKPLC CLIENT DIRECTOR LTD | Director | Calleva Park Aldermaston RG7 8NN Reading 5 Jupiter House Berkshire United Kingdom |
| 86283500001 |
Who are the persons with significant control of LDN PHARMA LIMITED?
Name | Notified On | Address | Ceased |
---|---|---|---|
Mr Paul Joseph Sweeney | Apr 06, 2016 | Gresham Street EC2V 7BG London 45 England | No |
Nationality: Irish Country of Residence: Ireland | |||
Natures of Control
| |||
Mr Ian Thompson | Apr 06, 2016 | Carricklee Road BT82 9SE Strabane 1 Tyrone Northern Ireland | No |
Nationality: Irish Country of Residence: United Kingdom | |||
Natures of Control
|
Data Source
- UK Companies House
The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings. - license: CC0